A major challenge in cancer treatment is the resistance of cancer cells to chemotherapeutic agents, which is mediated by several drug resistance-related drug transporters [1–2], particularly P-glycoprotein and multidrug resistance-associated protein 1 (MRP1). Here, ABCB1 is linked to cancer.